Augmedix Secures Strategic Financing from and Partners with HCA Healthcare to Accelerate the Development of AI-enabled Ambient Documentation

April 20, 2023

(24/7 MARKET NEWS) – Augmedix Inc. (NASSDAQ: AUGX) stated, this morning, that it executed a strategic financing with HCA Healthcare, Inc. (NYSE:HCA), which provides Augmedix with approximately $12 million in new capital and is expected to enable the Company to achieve positive cash flow without additional financing.

In a second announcement that it published this morning, Augmedix said that it’s partnering with HCA Healthcare to accelerate development of technology that aims to transform the way patient care is documented in the acute care setting.

Augmedix is trading at $2.32, up $0.52 (+28.88%), on 60K premarket shares traded.

Its 52-week range is $1.01 to $3.15. It’s cleared its recent resistance and has its September highs in its sights. If it gets the AI boost that turbocharged many of last week’s top gainers, who knows what this can do.

24/7 MARKET NEWS, INC Disclaimer

24/7 MARKET NEWS (“24/7 MN”) is dedicated to covering various underreported segments of the stock markets. Our goal is to help you to better understand these markets, but 24/7 MN is neither an investment advisor nor a financial advisor, and no information provided here is to be interpreted as a suggestion to buy or sell stocks or other investment products. All opinions, news, research, analysis, prices or other information contained on 247marketnews.com, its press releases, or other services are provided for educational purposes only and do not constitute investment advice. You are solely responsible for the investment decisions you make.

Please go to 247marketnews.com or https://247marketnews.com/terms-disclaimer/ for further information.

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.